BioPharmSignal logoBioPharmSignal

Biotech News

Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update

Talphera Inc (TLPH)TalpheraEarnings

NEPHRO CRRT clinical study expected to be completed this year Cash and investments of $21.1 million at March 31, 2026 Conference call and webcast to be held on Wednesday, May 13, 2026 at 4:30 pm ET SAN MATEO, Calif., May 13, 2026 /PRNewswire/ -- Talphera, Inc.

Related news

TLPHTalphera2026-05-07 20:05 EST

Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 13, 2026

TLPHTalphera2026-08-12 20:05 EST

Talphera Announces Second Quarter 2026 Financial Results and Provides Corporate Update

View all latest news

Talphera Inc

Talphera is a specialty pharmaceutical company focused on acute-care and pain management products. Its story is centered on hospital-oriented therapies and the challenge of commercial execution in acute care.

Recent company news

TLPHTalphera2026-09-03 12:30 EST

Talphera to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

TLPHTalphera2026-08-12 20:05 EST

Talphera Announces Second Quarter 2026 Financial Results and Provides Corporate Update

TLPHTalphera2026-08-05 20:05 EST

Talphera to Report Second Quarter 2026 Financial Results on Wednesday, August 12, 2026

TLPHTalphera2026-05-13 20:05 EST

Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update

TLPHTalphera2026-05-07 20:05 EST

Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 13, 2026

Stock data

Close
1.11 USD
Market cap
40.24M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States